NCT03245242

Brief Summary

The purpose of this research study is to evaluate an Enhanced Recovery After Surgery (ERAS) protocol in children and young adults undergoing urologic reconstructive surgery. The investigators plan to collect data on speed of recovery (how quickly pain improves, length of time in the hospital, and the need for additional pain control) on patients who receive care under the ERAS protocol and compare it to historical controls.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for all trials

Timeline
6mo left

Started Apr 2017

Longer than P75 for all trials

Geographic Reach
1 country

7 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Apr 2017Oct 2026

Study Start

First participant enrolled

April 1, 2017

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 28, 2017

Completed
13 days until next milestone

First Posted

Study publicly available on registry

August 10, 2017

Completed
9.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2026

Last Updated

December 26, 2025

Status Verified

December 1, 2025

Enrollment Period

9.6 years

First QC Date

July 28, 2017

Last Update Submit

December 18, 2025

Conditions

Keywords

enhanced recovery after surgeryurologic reconstructionpediatric urologybladder augmentationMitrofanoffMalone antegrade continence enema channelappendicovesicostomyileovesicostomyappendicocecostomy

Outcome Measures

Primary Outcomes (1)

  • Adherence to ERAS protocol

    Adherence to ERAS protocol items with # of items achieved (out of 20)

    3 years

Secondary Outcomes (8)

  • Length of stay

    3 years

  • Re-admissions within 30 days

    30 days

  • Re-operations within 90 days

    90 days

  • Number of visits to the emergency room within 90 day period

    90 days

  • Number of 30-day complications

    3 years

  • +3 more secondary outcomes

Study Arms (2)

Enhanced Recovery After Surgery

Prospectively enrolled group to receive standardized care under a set ERAS protocol/pathway.

Other: Enhanced Recovery after Surgery

Historical usual surgical care

Recent historical patients (5 years prior to start of ERAS) that will be propensity-matched to ERAS patients to be used as controls for comparison of outcomes.

Other: Historical usual surgical care

Interventions

Enhanced Recovery After Surgery (ERAS) protocol is a multi-disciplinary program that aims to standardize care processes around the pre-, intra-, and post-operative care setting. This group will prospectively receive care under a pre-defined protocol.

Enhanced Recovery After Surgery

Recent historical controls will have received care under "usual care" that existed prior to implementation of an enhanced recovery protocol.

Historical usual surgical care

Eligibility Criteria

Age4 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

There are 2 populations: 1. ERAS patients: a. ages 4-17 and, b. transitional young adult 18-25 2. Historical patients: a. ages 4-17 and, b. transitional young adult 18-25

You may qualify if:

  • Age greater than or equal to 4 or \<26 years at time of surgery
  • Undergoing urologic reconstructive surgery that includes primary bowel anastomosis (i.e., creation of continent ileovesicostomy \[Monti\], sigmoid Monti channel, enterocystoplasty)
  • Undergoing urologic reconstructive surgery that includes possible bowel anastomosis (planned creation of continent appendicovesicostomy \[Mitrofanoff\] with inability to use appendix at time of surgery and creation of alternative channel requiring primary bowel anastomosis)

You may not qualify if:

  • Clinically constipated (defined as Bristol 1 or 2 stools more than once per week, bowel movement interval \> every other day \[e.g. only has bowel movement every 3 days, or palpable stool in \> 50% of colon on physical preoperative exam)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Children's Hospital Colorado

Aurora, Colorado, 80045, United States

Location

Ann & Robert Lurie Children's Hospital of Chicago

Chicago, Illinois, 60611, United States

Location

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, 45229, United States

Location

Oklahoma University Health Science Center

Oklahoma City, Oklahoma, 72104, United States

Location

Children's Hospital of Pittsburgh of UPMC

Pittsburgh, Pennsylvania, 15224, United States

Location

Children's Hospital of Richmond at Virginia Commonwealth University

Richmond, Virginia, 23221, United States

Location

Related Publications (2)

  • Moore RP, Burjek NE, Brockel MA, Strine AC, Acks A, Boxley PJ, Chidambaran V, Vricella GJ, Chu DI, Sankaran-Raval M, Zee RS, Cladis FP, Chaudhry R, O'Reilly-Shah VN, Ahn JJ, Rove KO; PURSUE Study Group. Evaluating the role for regional analgesia in children with spina bifida: a retrospective observational study comparing the efficacy of regional versus systemic analgesia protocols following major urological surgery. Reg Anesth Pain Med. 2023 Jan;48(1):29-36. doi: 10.1136/rapm-2022-103823. Epub 2022 Sep 27.

  • Rove KO, Strine AC, Wilcox DT, Vricella GJ, Welch TP, VanderBrink B, Chu DI, Chaudhry R, Zee RS, Brockel MA; PURSUE Study group. Design and development of the Pediatric Urology Recovery After Surgery Endeavor (PURSUE) multicentre pilot and exploratory study. BMJ Open. 2020 Nov 23;10(11):e039035. doi: 10.1136/bmjopen-2020-039035.

MeSH Terms

Conditions

Urinary Bladder, NeurogenicUrinary Bladder Diseases

Interventions

Enhanced Recovery After Surgery

Condition Hierarchy (Ancestors)

Neurologic ManifestationsNervous System DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Perioperative CareSurgical Procedures, Operative

Study Officials

  • Douglas Coplen, M.D.

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2017

First Posted

August 10, 2017

Study Start

April 1, 2017

Primary Completion (Estimated)

October 31, 2026

Study Completion (Estimated)

October 31, 2026

Last Updated

December 26, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations